Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia
Gasic, Vladimir, Zukic, Branka, Stankovic, Biljana, Janic, Dragana, Dokmanovic, Lidija, Lazic, Jelena, Krstovski, Nada, Dolzan, Vita, Jazbec, Janez, Pavlovic, Sonja, Kotur, Nikola
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
Kotnik, Barbara Faganel, Jazbec, Janez, Grabar, Petra Bohanec, Rodriguez-Antona, Cristina, Dolzan, Vita
Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience
Crepinsek, Klementina, Marinsek, Gasper, Kavcic, Marko, Prelog, Tomaž, Kitanovski, Lidija, Jazbec, Janez, Debeljak, Marusa
Trends in treatment of childhood cancer and subsequent primary neoplasm risk
Cesen Mazic, Maja, Reulen, Raoul C., Jazbec, Janez, Zadravec Zaletel, Lorna
The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma
Erculj, Nina, Kotnik, Barbara Faganel, Debeljak, Marusa, Jazbec, Janez, Dolzan, Vita
Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
Vodusek, Ana Lina, Goricar, Katja, Gazic, Barbara, Dolzan, Vita, Jazbec, Janez
Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries
Mazic, Maja Cesen, Bonevski, Aleksandra, Mikeskova, Martina, Mihut, Emilia, Bisogno, Gianni, Jazbec, Janez
Trends in treatment of childhood cancer and subsequent primary neoplasm risk
Cesen Mazic, Maja, Reulen, Raoul C., Jazbec, Janez, Zadravec Zaletel, Lorna